As reported in other public filings for the Reporting Person and Issuer, the Reporting Person entered into a written plan for the purchase of Retractable Technologies, Inc. common stock intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) on August 22, 2024. In accordance with the plan, trading began November 20, 2025 and may continue through November 19, 2025 if not earlier terminated.

16,476,925 (55.0%)

Sole power to vote 15,976,925 shares and sole power to dispose 16,145,325 shares

All of the following open market common stock purchases were made by Mr. Shaw's broker pursuant to his 10b5-1 Plan and reported on Form 4 in the last 60 days. All prices are expressed as weighted average per share prices: 06/30/25 - 1,347 shares at $0.6221; 07/01/25 - 8,574 shares at $0.628; 07/11/25 - 8,536 shares at $0.653; 07/21/25 - 5,000 shares at $0.66; 07/30/25 - 27,288 shares at $0.7358; 07/31/25 - 5,339 shares at $0.7147; 08/01/25 - 1,575 shares at $0.703; 08/04/25 - 30,881 shares at $0.7157; 08/07/25 - 49,541 shares at $0.74; 08/11/25 - 2,100 shares at $0.8118; 08/12/25 - 8,411 shares at $0.823; 08/13/25 - 3,983 shares at $0.8015; 08/14/25 - 3,103 shares at $0.7875; 8/15/25 - 10,980 shares at $0.7948; 08/18/25 - 32,935 shares at $0.795; 08/19/25 - 9,042 shares at $0.7963.

The beneficiaries of two trusts have the right to receive dividends from, or the proceeds from the sale of, the following number of shares of common stock beneficially owned by Mr. Shaw: (i) 331,600 shares; and (ii) 500,000 shares.